Site map

• Guidelines
  • Whole blood and components
    • A to Z
      • Accident
      • Acid indigestion
      • Acne
      • Addiction and drug abuse
      • Adrenal failure
      • Age
      • Air crew and air traffic controllers
      • Allergy
      • Alopecia
      • Anaemia
      • Anaesthetic
      • Animal bite, non-human
      • Anti-androgens
      • Antibiotic therapy
      • Anticoagulant therapy
      • Arrhythmias
      • Asthma
      • Autoimmune disease
      • Back problems
      • Bleeding disorder
      • Blood pressure, high
      • Blood pressure, low
      • Blood safety
      • Body piercing
      • Breastfeeding
      • Cardiac surgery
      • Cardiovascular disease (CVD)
      • Catarrh
      • Central nervous system (CNS) disease
      • Cerebrovascular disease and intracranial haemorrhage
      • Cervical dysplasia
      • Chest pain
      • Chiropody
      • Chondromalacia
      • Chronic fatigue syndrome (CFS)
      • Clinical trials
      • Clopidogrel
      • Coeliac disease
      • Communication difficulties
      • Complementary therapy
      • Conn's syndrome
      • Contraceptive use
      • Coronavirus infection
      • Decompression illness
      • Dental treatment
      • Dermatitis
      • Diabetes insipidus
      • Diabetes mellitus
      • Disabled donor
      • Diuretics
      • Diverticular disease
      • Drug treatment
      • Ehlers-Danlos syndrome (EDS)
      • Endocarditis
      • Endometriosis
      • Endoscopy
      • Epilepsy
      • Erectile dysfunction
      • Etretinate
      • Exercise
      • Eye disease
      • Faints
      • Familial pseudohyperkalaemia (FP)
      • Fertility
      • Fibromyalgia
      • Frequency of donation
      • Gall bladder disease
      • Gastroenteritis
      • Gastrointestinal disease
      • Giardiasis
      • Glycogen storage disease (GSD)
      • Gout
      • Growth hormone (GH)
      • Guillain-Barré syndrome
      • Haematological disease
      • Haematuria
      • Haemochromatosis
      • Haemoglobin disorders
      • Haemoglobin estimation
      • Haemolytic anaemia
      • Haemorrhoids
      • Hair removal
      • Hazardous activity
      • Headache
      • Healthcare worker
      • Henna painting
      • Hepatitis
      • Hepatitis A
      • Hepatitis B
      • Hepatitis C
      • Hepatitis E
      • Hepatitis of unknown origin
      • Herpes simplex
      • Hormone replacement therapy (HRT)
      • Human immunodeficiency virus (HIV)
      • Human T-cell lymphotropic virus (HTLV)
      • Huntington's disease
      • Hydrocephalus
      • Hypercholesterolaemia
      • Hypnotics
      • Immune thrombocytopenia
      • Immunisation
      • Immunisation, live
      • Immunisation, non-live
      • Immunodeficiency
      • Immunoglobulin therapy
      • Infection, acute
      • Infection, chronic
      • Infection, general
      • Infectious diseases, contact with
      • Inflammatory bowel disease (IBD)
      • Inherited diseases
      • Investigations
      • Irritable bowel syndrome (IBS)
      • Jaundice
      • Kidney and bladder disease
      • Klinefelter syndrome
      • Laser treatment
      • Liver disease
      • Malaria
      • Malaria - plasmapheresis donors
      • Malignancy
      • Marfan syndrome
      • Ménière’s disease
      • Menopause
      • Mental health problems
      • Migraine
      • Monoclonal antibody therapy and other biological modalities
      • Mpox
      • Narcolepsy
      • Neurobehavioural disorders
      • Neurofibromatosis (NF)
      • Neurosurgery
      • Night sweats
      • Non-consented exposure to human body fluids
      • Non-contagious diseases, contact with
      • Nonsteroidal anti-inflammatory drugs (NSAIDs)
      • Nose bleeds
      • Oseltamivir
      • Osteoarthritis
      • Osteomyelitis
      • Osteopenia
      • Paget's disease of bone
      • Painkillers
      • Palpitations
      • Parvovirus B19
      • Peptic ulcer
      • Periods
      • Perthes disease
      • Pituitary disorders
      • Platelet count
      • Platelet disorders
      • Pneumothorax
      • Polycystic ovary syndrome (PCOS)
      • Polycythaemia and raised haemoglobin
      • Porphyria
      • Pre- and post-exposure prophylaxis (PrEP, PEP) for HIV prevention
      • Pregnancy
      • Prion-associated diseases
      • Proctitis
      • Prostate problems
      • Psoriasis
      • Pyrexia
      • Rabies
      • Radiation therapy
      • Radionuclides
      • Raynaud's syndrome
      • Respiratory disease
      • Rheumatic fever
      • Sarcoidosis
      • Sex worker
      • Sexually transmitted disease (STD)
      • Shunts, stents and devices
      • Sickle cell trait
      • Skin disease
      • Sleep apnoea
      • Smallpox immunisation
      • Smoking
      • Smoking cessation
      • South American trypanosomiasis
      • South American trypanosomiasis - plasmapheresis donors
      • Spina bifida
      • Splenectomy
      • Steroid therapy
      • Stoma
      • Superficial thrombophlebitis
      • Surgery
      • Syphilis
      • Tendonitis
      • Tetanus
      • Threadworms
      • Thrombosis and thrombophilia
      • Thrush
      • Thyroid disease
      • Tissue and organ recipients
      • Topical medication
      • Toxoplasmosis
      • Transfusion
      • Transgender and non-binary individuals
      • Travel
      • Tropical viruses
      • Tropical viruses - plasmapheresis donors
      • Tuberculin PPD test
      • Tuberculosis (TB)
      • Turner syndrome
      • Urinary catheterisation
      • Valproate and topiramate
      • Varicose veins and chronic venous insufficiency
      • Vertigo
      • Viral haemorrhagic fever (VHF)
      • Vitamins and other nutritional supplements
      • Warts
      • Weight
      • Weight loss medication
      • West Nile Virus (WNV)
      • West Nile Virus (WNV) - plasmapheresis donors
      • Wounds, mouth and skin ulcers
      • Xenotransplantation
      • Xenotropic murine leukemia virus-related virus (XMRV)
      • Zanamivir
      • Testosterone replacement therapy (TRT)
    • Updates
    • Source files
    • Drugs and platelet donation
    • Using these guidelines
    • Appendix 1: Estimated blood volume for female donors
    • Appendix 3: Maximum permitted extracorporeal volume (ECV) for component donors
    • Appendix 4: Management of post donation illness
    • Appendix 2: Immunisations
  • Geographical Disease Risk Index
    • A to Z
      • Afghanistan
      • Aland (Åland) Islands
      • Albania
      • Algeria
      • American Samoa
      • Andorra
      • Angola
      • Anguilla
      • Antarctica
      • Antigua and Barbuda
      • Argentina
      • Armenia
      • Aruba
      • Australia
      • Austria
      • Azerbaijan
      • Bahamas, The
      • Bahrain
      • Bangladesh
      • Barbados
      • Belarus
      • Belgium
      • Belize
      • Benin
      • Bermuda
      • Bhutan
      • Bolivia
      • Bonaire, Sint Eustatius and Saba
      • Bosnia and Herzegovina
      • Botswana
      • Bouvet Island
      • Brazil
      • British Indian Ocean Territory (BIOT)
      • British Virgin Islands (BVI)
      • Brunei Darussalam
      • Bulgaria
      • Burkina Faso
      • Burundi
      • Cambodia
      • Cameroon
      • Canada
      • Cape Verde
      • Cayman Islands
      • Central African Republic (CAR)
      • Chad
      • Chile
      • China
      • Christmas Island
      • Cocos (Keeling) Islands
      • Colombia
      • Comoros
      • Congo, Democratic Republic of the (DRC)
      • Congo, Republic of the
      • Cook Islands
      • Costa Rica
      • Cote (Côte) d'Ivoire
      • Croatia
      • Cuba
      • Curacao (Curaçao)
      • Cyprus
      • Czechia
      • Denmark
      • Djibouti
      • Dominica
      • Dominican Republic
      • Timor Leste
      • Ecuador
      • Egypt
      • El Salvador
      • Equatorial Guinea
      • Eritrea
      • Estonia
      • Eswatini
      • Ethiopia
      • Falkland Islands
      • Faroe Islands
      • Fiji
      • Finland
      • France
      • French Guiana
      • French Polynesia
      • French Southern Territories and Antarctic Lands
      • Gabon
      • Gambia, The
      • Georgia
      • Germany
      • Ghana
      • Gibraltar
      • Golan Heights
      • Greece
      • Greenland
      • Grenada
      • Guadeloupe
      • Guam
      • Guatemala
      • Guernsey
      • Guinea
      • Guinea-Bissau
      • Guyana
      • Haiti
      • Heard Island and McDonald Islands
      • Honduras
      • Hong Kong
      • Hungary
      • Iceland
      • India
      • Indonesia
      • Iran
      • Iraq
      • Ireland
      • Isle of Man
      • Israel
      • Italy
      • Jamaica
      • Japan
      • Jersey
      • Jordan
      • Kazakhstan
      • Kenya
      • Kiribati
      • Kosovo
      • Kuwait
      • Kyrgyzstan
      • Laos
      • Latvia
      • Lebanon
      • Lesotho
      • Liberia
      • Libya
      • Liechtenstein
      • Lithuania
      • Luxembourg
      • Macao (Macau)
      • Madagascar
      • Malawi
      • Malaysia
      • Maldives
      • Mali
      • Malta
      • Marshall Islands
      • Martinique
      • Mauritania
      • Mauritius
      • Mayotte
      • Mexico
      • Micronesia
      • Moldova
      • Monaco
      • Mongolia
      • Montenegro
      • Montserrat
      • Morocco
      • Mozambique
      • Myanmar
      • Namibia
      • Nauru
      • Nepal
      • Netherlands
      • New Caledonia
      • New Zealand
      • Nicaragua
      • Niger
      • Nigeria
      • Niue
      • Norfolk Island
      • North Korea
      • North Macedonia
      • Northern Mariana Islands
      • Norway
      • Oman
      • Pakistan
      • Palau
      • Panama
      • Papua New Guinea
      • Paraguay
      • Peru
      • Philippines
      • Pitcairn Islands
      • Poland
      • Portugal
      • Puerto Rico
      • Qatar
      • Reunion (Réunion)
      • Romania
      • Russia
      • Rwanda
      • Saint Barthelemy
      • Saint Helena, Ascension and Tristan da Cunha
      • Saint Kitts and Nevis
      • Saint Lucia
      • Saint Martin
      • Saint Pierre and Miquelon
      • Saint Vincent and the Grenadines
      • Samoa
      • San Marino
      • Sao Tome and Principe (São Tomé and Príncipe)
      • Saudi Arabia
      • Senegal
      • Serbia
      • Seychelles
      • Sierra Leone
      • Singapore
      • Sint Maarten
      • Slovakia
      • Slovenia
      • Solomon Islands
      • Somalia
      • South Africa
      • South Georgia and the South Sandwich Islands
      • South Korea
      • South Sudan
      • Spain
      • Sri Lanka
      • Sudan
      • Suriname
      • Svalbard and Jan Mayen
      • Sweden
      • Switzerland
      • Syria
      • Taiwan
      • Tajikistan
      • Tanzania
      • Thailand
      • Togo
      • Tokelau
      • Tonga
      • Trinidad and Tobago
      • Tunisia
      • Turkey
      • Turkmenistan
      • Turks and Caicos Islands
      • Tuvalu
      • Uganda
      • Ukraine
      • United Arab Emirates (UAE)
      • United Kingdom (UK)
      • United States of America (USA)
      • United States Minor Outlying Islands (USMOI)
      • United States Virgin Islands (USVI)
      • Uruguay
      • Uzbekistan
      • Vanuatu
      • Vatican City
      • Venezuela
      • Vietnam
      • Wallis and Futuna
      • Palestine
      • Western Sahara
      • Yemen
      • Zambia
      • Zimbabwe
      • Borneo
      • Caribbean
      • Polynesia
      • West Indies
    • Source files
    • Updates
    • Cross-references to relevant entries in the donor selection guidelines
    • Using these guidelines
  • Tissue (deceased donors)
    • A to Z
      • Acanthamoeba (ocular infection)
      • Accident
      • Achondroplasia
      • Addiction and drug abuse
      • African trypanosomiasis
      • Age
      • Alcoholism
      • Allergy
      • Anaemia
      • Animal bite, non-human
      • Ankylosing spondylitis (AS)
      • Anthrax
      • Antibiotic therapy
      • Arthritis
      • Asthma
      • Autoimmune disease
      • Avascular necrosis of the femoral head (hip)
      • Babesiosis
      • Bacillus Calmette-Guérin (BCG)
      • Basal cell carcinoma (BCC)
      • Bleeding disorder
      • Blind donor
      • Blood pressure, high
      • Body piercing
      • Breast lump
      • Breastfeeding
      • Bronchitis
      • Brucellosis
      • Cardiac surgery
      • Cardiomyopathy
      • Cardiovascular disease (CVD)
      • Catarrh
      • Central nervous system (CNS) disease
      • Cervical dysplasia
      • Chickenpox
      • Chondromalacia
      • Chronic fatigue syndrome (CFS)
      • Cirrhosis
      • Clinical trials
      • Coeliac disease
      • Colostomy
      • Communication difficulties
      • Complementary therapy
      • Congo fever
      • Contact lenses
      • Contraceptive implant
      • Contraceptive injection
      • Contraceptive pill
      • Corneal transplant
      • Coronary thrombosis
      • Coronavirus infection
      • Death from unknown causes
      • Deep vein thrombosis (DVT)
      • Dementia
      • Dermatitis
      • Diabetes insipidus
      • Diabetes mellitus
      • Diarrhoea
      • Disabled donor
      • Disease of unknown aetiology
      • Diverticulosis
      • Down's syndrome
      • Drowning
      • Drug treatment
      • Edwards' syndrome
      • Ehlers-Danlos syndrome (EDS)
      • Electrolysis
      • Emphysema
      • Encephalitis
      • Endocarditis
      • Endometriosis
      • Epilepsy
      • Eye disease
      • Eye drops
      • Factor V Leiden
      • Fertility
      • Fibromyalgia
      • Filariasis
      • Gall bladder disease
      • Giardiasis
      • Gilbert's syndrome
      • Glasses
      • Glaucoma
      • Glucose-6-phosphate dehydrogenase (G6PD) deficiency
      • Gout
      • Granuloma inguinale
      • Growth hormone (GH)
      • Guillain-Barré syndrome
      • Haematological disease
      • Haematuria
      • Haemochromatosis
      • Haemoglobin disorders
      • Haemolytic anaemia
      • Haemorrhoids
      • Headache
      • Heaf test
      • Healthcare worker
      • Henna painting
      • Hepatitis
      • Hepatitis A
      • Hepatitis B
      • Hepatitis C
      • Hepatitis E
      • Hepatitis of unknown origin
      • Hereditary elliptocytosis
      • Hereditary spherocytosis
      • Herpes, genital
      • Herpes, ocular
      • Herpes, oral
      • Herpes simplex
      • Herpes zoster
      • Hip dysplasia
      • Hormone replacement and sex hormone therapy
      • Human immunodeficiency virus (HIV)
      • Human T-cell lymphotropic virus (HTLV)
      • Huntington's disease
      • Hydatid disease
      • Hydrocephalus
      • Hypnotics
      • Ileostomy
      • Immune thrombocytopenia
      • Immunisation
      • Immunisation, live
      • Immunisation, non-live
      • Immunoglobulin therapy
      • Immunosuppression
      • Infection, acute
      • Infection, chronic
      • Infection, general
      • Infection, tropical
      • Infectious diseases, contact with
      • Inflammatory bowel disease (IBD)
      • Inherited diseases
      • Inoculation injury
      • Irritable bowel syndrome (IBS)
      • Jaundice
      • Kidney disease
      • Klinefelter syndrome
      • Laser treatment
      • Leishmaniasis
      • Leukaemia
      • Malaria
      • Malaria - contact in the UK
      • Malignancy
      • Malignant hypertension
      • Mantoux test
      • Marfan syndrome
      • Measles
      • Ménière's disease
      • Meningitis
      • Menopause
      • Mental health problems
      • Methicillin resistant staphylococcus aureus (MRSA)
      • Mitral valve prolapse
      • Mpox
      • Multiple sclerosis (MS)
      • Mumps
      • Muscular dystrophy
      • Myasthenia gravis (MG)
      • Myelodysplastic syndrome (MDS)
      • Myeloproliferative syndrome
      • Myocarditis
      • Necrotising soft tissue infections
      • Neurofibromatosis (NF)
      • Neurosurgery
      • Night sweats
      • Non-specific urethritis (NSU)
      • Nonsteroidal anti-inflammatory drugs (NSAIDs)
      • Ocular surgery
      • Ocular tissue recipient
      • Organ donor
      • Organ recipient
      • Osteoarthritis
      • Osteogenesis imperfecta (OI)
      • Osteomalacia
      • Osteomyelitis
      • Osteoporosis
      • Ovarian cyst
      • Paget's disease of bone
      • Painkillers
      • Peptic ulcer
      • Perthes disease
      • Pituitary extract, human
      • Plasma dilution
      • Platelet disorders
      • Pleurisy
      • Pneumothorax
      • Poisoning
      • Polycythaemia
      • Porphyria
      • Pre- and post-exposure prophylaxis (PrEP, PEP) for HIV prevention
      • Pregnancy
      • Prion-associated diseases
      • Prisons
      • Progressive multifocal leukoencephalopathy (PML)
      • Psoriasis
      • Pulmonary embolism (PE)
      • Pyelonephritis
      • Pyrexia
      • Pyruvate kinase deficiency (PKD)
      • Q fever
      • Quinsy
      • Rabies
      • Radiation therapy
      • Radionuclides
      • Raynaud's syndrome
      • Recipients of normal human immunoglobulin
      • Renal colic
      • Respiratory disease
      • Retinitis pigmentosa (RP)
      • Reye's syndrome
      • Rheumatic fever
      • Rheumatoid arthritis (RA)
      • Ringworm
      • Rubella
      • Sarcoidosis
      • Sex worker
      • Sexually transmitted disease (STD)
      • Shingles
      • Sickle cell trait
      • Sideroblastic anaemia
      • Skin disease
      • Smallpox immunisation
      • South American trypanosomiasis
      • South American trypanosomiasis, risk of
      • Spina bifida
      • Spinal surgery
      • Splenectomy
      • Steroid therapy
      • Stroke
      • Syphilis
      • Systemic lupus erythematosus (SLE)
      • Tamoxifen
      • Tetanus immunisation
      • Thalassaemia major
      • Thalassaemia trait
      • Tropical viruses
      • Therapeutic venesection
      • Threadworms
      • Thrombocytosis
      • Thrombosis
      • Thrush, oral
      • Thrush, vaginal
      • Thyroid disease
      • Tissue and cell allograft recipients
      • Tissues safety
      • Toxoplasmosis
      • Transfusion
      • Transgender and non-binary individuals
      • Travel
      • Trypanosoma cruzi infection
      • Tuberculosis (TB)
      • Turner syndrome
      • Vasculitis
      • Viral haemorrhagic fever (VHF)
      • Vitamin treatment
      • Warts
      • Warts, genital
      • West Nile Virus (WNV)
      • Whooping cough
      • Wilson's disease
      • Xenotransplantation
      • Xenotropic murine leukemia virus-related virus (XMRV)
      • Yaws
    • Updates
    • Source files
    • Appendix 1: Medical criteria for the withdrawal of donations following information received after donation
    • Appendix 2: Calculation of blood and plasma dilution
    • Appendix 4: Grading of selected central nervous system tumours (WHO 2016 classification)
    • Using these guidelines
    • Appendix 3: Immunisations
  • Tissue (live donors)
    • A to Z
      • Achondroplasia
      • Addiction and drug abuse
      • African trypanosomiasis
      • Age
      • Alcoholism
      • Allergy
      • Anaemia
      • Animal bite, non-human
      • Ankylosing spondylitis (AS)
      • Anthrax
      • Antibiotic therapy
      • Arthritis
      • Asthma
      • Autoimmune disease
      • Avascular necrosis of the femoral head (hip)
      • Babesiosis
      • Bacillus Calmette-Guérin (BCG)
      • Basal cell carcinoma (BCC)
      • Bleeding disorder
      • Blood pressure, high
      • Body piercing
      • Breast lump
      • Bronchitis
      • Brucellosis
      • Cardiac surgery
      • Cardiomyopathy
      • Cardiovascular disease (CVD)
      • Catarrh
      • Central nervous system (CNS) disease
      • Cervical dysplasia
      • Chickenpox
      • Chondromalacia
      • Chronic fatigue syndrome (CFS)
      • Cirrhosis
      • Clinical trials
      • Coeliac disease
      • Colostomy
      • Communication difficulties
      • Complementary therapy
      • Congo fever
      • Contraceptive implant
      • Contraceptive injection
      • Contraceptive pill
      • Corneal transplant
      • Coronary thrombosis
      • Coronavirus infection
      • Deep vein thrombosis (DVT)
      • Dementia
      • Dermatitis
      • Diabetes insipidus
      • Diabetes mellitus
      • Diarrhoea
      • Disabled donor
      • Disease of unknown aetiology
      • Diverticulosis
      • Drug treatment
      • Ehlers-Danlos syndrome (EDS)
      • Electrolysis
      • Emphysema
      • Endocarditis
      • Endometriosis
      • Epilepsy
      • Eye disease
      • Eye drops
      • Factor V Leiden
      • Fertility
      • Fibromyalgia
      • Filariasis
      • Gall bladder disease
      • Giardiasis
      • Gilbert's syndrome
      • Glaucoma
      • Glucose-6-phosphate dehydrogenase (G6PD) deficiency
      • Gout
      • Granuloma inguinale
      • Growth hormone (GH)
      • Guillain-Barré syndrome
      • Haematological disease
      • Haematuria
      • Haemochromatosis
      • Haemoglobin disorders
      • Haemolytic anaemia
      • Haemorrhoids
      • Headache
      • Heaf test
      • Healthcare worker
      • Henna painting
      • Hepatitis
      • Hepatitis A
      • Hepatitis B
      • Hepatitis C
      • Hepatitis E
      • Hepatitis of unknown origin
      • Hereditary elliptocytosis
      • Hereditary spherocytosis
      • Herpes, genital
      • Herpes, oral
      • Herpes simplex
      • Herpes zoster
      • Hip dysplasia
      • Hormone replacement and sex hormone therapy
      • Human immunodeficiency virus (HIV)
      • Human T-cell lymphotropic virus (HTLV)
      • Huntington's disease
      • Hydatid disease
      • Hydrocephalus
      • Hypnotics
      • Ileostomy
      • Immune thrombocytopenia
      • Immunisation
      • Immunisation, live
      • Immunisation, non-live
      • Immunoglobulin therapy
      • Immunosuppression
      • Infection, acute
      • Infection, chronic
      • Infection, general
      • Infection, tropical
      • Infectious diseases, contact with
      • Inflammatory bowel disease (IBD)
      • Inherited diseases
      • Inoculation injury
      • Irritable bowel syndrome (IBS)
      • Jaundice
      • Kidney disease
      • Klinefelter syndrome
      • Laser treatment
      • Leishmaniasis
      • Leukaemia
      • Malaria
      • Malaria - contact in the UK
      • Malignancy
      • Malignant hypertension
      • Mantoux test
      • Marfan syndrome
      • Measles
      • Ménière's disease
      • Meningitis
      • Menopause
      • Mental health problems
      • Methicillin resistant staphylococcus aureus (MRSA)
      • Mitral valve prolapse
      • Mpox
      • Multiple sclerosis (MS)
      • Mumps
      • Muscular dystrophy
      • Myasthenia gravis (MG)
      • Myelodysplastic syndrome (MDS)
      • Myeloproliferative syndrome
      • Myocarditis
      • Neurofibromatosis (NF)
      • Neurosurgery
      • Night sweats
      • Non-specific urethritis (NSU)
      • Nonsteroidal anti-inflammatory drugs (NSAIDs)
      • Ocular surgery
      • Ocular tissue recipient
      • Organ donor
      • Organ recipient
      • Osteoarthritis
      • Osteogenesis imperfecta (OI)
      • Osteomalacia
      • Osteomyelitis
      • Osteoporosis
      • Ovarian cyst
      • Paget's disease of bone
      • Painkillers
      • Peptic ulcer
      • Perthes disease
      • Pituitary extract, human
      • Platelet disorders
      • Pleurisy
      • Poisoning
      • Polycythaemia
      • Porphyria
      • Pre- and post-exposure prophylaxis (PrEP, PEP) for HIV prevention
      • Pregnancy
      • Prion-associated diseases
      • Psoriasis
      • Pulmonary embolism (PE)
      • Pyrexia
      • Pyruvate kinase deficiency (PKD)
      • Q fever
      • Rabies
      • Radiation therapy
      • Radionuclides
      • Raynaud's syndrome
      • Recipients of normal human immunoglobulin
      • Reiter's syndrome
      • Renal colic
      • Respiratory disease
      • Retinitis pigmentosa (RP)
      • Rheumatic fever
      • Rheumatoid arthritis (RA)
      • Ringworm
      • Rubella
      • Sarcoidosis
      • Sex worker
      • Sexually transmitted disease (STD)
      • Shingles
      • Sickle cell trait
      • Skin disease
      • Smallpox immunisation
      • Snake bite
      • South American trypanosomiasis
      • South American trypanosomiasis, risk of
      • Spina bifida
      • Spinal surgery
      • Splenectomy
      • Steroid therapy
      • Stroke
      • Syphilis
      • Systemic lupus erythematosus (SLE)
      • Tamoxifen
      • Tetanus immunisation
      • Thalassaemia major
      • Thalassaemia trait
      • Therapeutic venesection
      • Threadworms
      • Thrombocytosis
      • Thrombosis
      • Thrush, oral
      • Thrush, vaginal
      • Thyroid disease
      • Tissue and cell allograft recipients
      • Tissues safety
      • Toxoplasmosis
      • Transfusion
      • Transgender and non-binary individuals
      • Travel
      • Tropical viruses
      • Trypanosoma cruzi infection
      • Tuberculosis (TB)
      • Turner syndrome
      • Vasculitis
      • Viral haemorrhagic fever (VHF)
      • Vitamin treatment
      • Warts
      • Warts, genital
      • West Nile Virus (WNV)
      • Whooping cough
      • Wilson's disease
      • Xenotransplantation
      • Xenotropic murine leukemia virus-related virus (XMRV)
      • Yaws
    • Updates
    • Source files
    • Appendix 1: Medical criteria for the withdrawal of donations following information received after donation
    • Using these guidelines
    • Appendix 2: Immunisations
  • Bone marrow and peripheral blood stem cells
    • A to Z
      • Accident
      • Acetylcholinesterase (AChE) deficiency
      • Addiction and drug abuse
      • Adrenal failure
      • African trypanosomiasis
      • Age
      • Allergy
      • Anaemia
      • Anaesthetic
      • Angina pectoris
      • Animal bite, non-human
      • Ankylosing spondylitis (AS)
      • Anthrax
      • Antibiotic therapy
      • Anticoagulant therapy
      • Anticonvulsant therapy
      • Antihistamine tablets
      • Arrhythmias
      • Arthritis
      • Asthma
      • Autoimmune disease
      • Babesiosis
      • Bacillus Calmette-Guérin (BCG)
      • Back problems
      • Basal cell carcinoma (BCC)
      • Beta blockers
      • Bleeding disorder
      • Blood pressure, high
      • Blood pressure, low
      • Blood volume estimation
      • Body piercing
      • Breast lump
      • Bronchitis
      • Brucellosis
      • Cardiac surgery
      • Cardiomyopathy
      • Cardiovascular disease (CVD)
      • Catarrh
      • Central nervous system (CNS) disease
      • Cerebrovascular disease
      • Cervical dysplasia
      • Chickenpox
      • Chiropody
      • Chondromalacia
      • Clinical trials
      • Clopidogrel
      • Coeliac disease
      • Colostomy
      • Communication difficulties
      • Complementary therapy
      • Congo fever
      • Contraceptive implant
      • Contraceptive injection
      • Contraceptive pill
      • Corneal transplant
      • Coronary thrombosis
      • Coronavirus infection
      • Coronavirus vaccination
      • Dementia
      • Dental treatment
      • Dermatitis
      • Diabetes insipidus
      • Diabetes mellitus
      • Diarrhoea
      • Digoxin
      • Dilatation and curettage
      • Disabled donor
      • Disease of unknown aetiology
      • Diuretics
      • Diverticulosis
      • Drug treatment
      • Electrolysis
      • Emphysema
      • Endocarditis
      • Endometriosis
      • Epilepsy
      • Eye disease
      • Eye drops
      • Faints
      • Fertility
      • Filariasis
      • Gall bladder disease
      • Granulocyte colony-stimulating factor (G-CSF)
      • Giardiasis
      • Glaucoma
      • Glucose-6-phosphate dehydrogenase (G6PD) deficiency
      • Glycogen storage disease (GSD)
      • Gout
      • Granuloma inguinale
      • Growth hormone (GH)
      • Guillain-Barré syndrome
      • Haematological disease
      • Haematuria
      • Haemochromatosis
      • Haemoglobin disorders
      • Haemolytic anaemia
      • Haemorrhoids
      • Hazardous activity
      • Headache
      • Heaf test
      • Healthcare worker
      • Henna painting
      • Hepatitis
      • Hepatitis A
      • Hepatitis B
      • Hepatitis C
      • Hepatitis E
      • Hepatitis of unknown origin
      • Hereditary elliptocytosis
      • Hereditary spherocytosis
      • Herpes, genital
      • Herpes, oral
      • Herpes simplex
      • Herpes zoster
      • Hormone replacement therapy (HRT)
      • Human immunodeficiency virus (HIV)
      • Human T-cell lymphotropic virus (HTLV)
      • Huntington's disease
      • Hydatid disease
      • Hydrocephalus
      • Hypercholesterolaemia
      • Hypnotics
      • Ileostomy
      • Immune thrombocytopenia
      • Immunisation
      • Immunisation, live
      • Immunisation, non-live
      • Immunoglobulin A (IgA) deficiency
      • Immunoglobulin therapy
      • Immunosuppression
      • Infection, acute
      • Infection, chronic
      • Infection, general
      • Infection, tropical
      • Infectious diseases, contact with
      • Inflammatory bowel disease (IBD)
      • Inherited diseases
      • Inoculation injury
      • Intermittent claudication
      • Irritable bowel syndrome (IBS)
      • Jaundice
      • Kidney disease
      • Klinefelter syndrome
      • Laser treatment
      • Leishmaniasis
      • Leukaemia
      • Liver disease
      • Malaria
      • Malaria - contact in the UK
      • Malignancy
      • Mantoux test
      • Marfan syndrome
      • Measles
      • Ménière's disease
      • Meningitis
      • Menopause
      • Mental health problems
      • Methicillin resistant staphylococcus aureus (MRSA)
      • Migraine
      • Mpox
      • Multiple sclerosis
      • Mumps
      • Muscular dystrophy
      • Myasthenia gravis (MG)
      • Myelodysplastic syndrome (MDS)
      • Myeloproliferative syndrome
      • Myocarditis
      • Narcolepsy
      • Neurofibromatosis (NF)
      • Neurosurgery
      • Night sweats
      • Non-specific urethritis (NSU)
      • Nonsteroidal anti-inflammatory drugs (NSAIDs)
      • Ocular surgery
      • Ocular tissue recipient
      • Operations
      • Organ donor
      • Organ recipient
      • Osteoarthritis
      • Osteomalacia
      • Osteomyelitis
      • Osteoporosis
      • Ovarian cyst
      • Paget's disease of bone
      • Painkillers
      • Peptic ulcer
      • Periods
      • Perthes disease
      • Phlebitis
      • Pituitary extract, human
      • Platelet disorders
      • Pleurisy
      • Pneumothorax
      • Poisoning
      • Polycystic kidney disease
      • Polycythaemia
      • Porphyria
      • Post-viral fatigue syndrome
      • Pre- and post-exposure prophylaxis (PrEP, PEP) for HIV prevention
      • Pregnancy
      • Prion-associated diseases
      • Psoriasis
      • Pyrexia
      • Pyruvate kinase deficiency (PKD)
      • Q fever
      • Rabies
      • Radiation therapy
      • Radionuclides
      • Raynaud's syndrome
      • Recipients of normal human immunoglobulin
      • Reiter's syndrome
      • Renal colic
      • Respiratory disease
      • Retinitis pigmentosa (RP)
      • Rheumatic fever
      • Rheumatoid arthritis (RA)
      • Ringworm
      • Rubella
      • Sarcoidosis
      • Self-catheterisation
      • Sex worker
      • Sexually transmitted disease (STD)
      • Shingles
      • Sickle cell trait
      • Skin disease
      • Smallpox immunisation
      • Smoking cessation
      • Snake bite
      • South American trypanosomiasis
      • South American trypanosomiasis, risk of
      • Spina bifida
      • Spinal surgery
      • Splenectomy
      • Steroid therapy
      • Stroke
      • Surgery
      • Syphilis
      • Systemic lupus erythematosus (SLE)
      • Tamoxifen
      • Tetanus immunisation
      • Thalassaemia major
      • Therapeutic venesection
      • Threadworms
      • Thrombosis and thrombophilia
      • Thrush, oral
      • Thrush, vaginal
      • Thyroid disease
      • Tissue and cell allograft recipients
      • Tissues safety
      • Topical medication
      • Toxoplasmosis
      • Transfusion
      • Transgender individuals
      • Transient ischaemic attack (TIA)
      • Travel
      • Tropical viruses
      • Trypanosoma cruzi infection
      • Tuberculosis (TB)
      • Turner syndrome
      • Varicose veins
      • Vasculitis
      • Viral haemorrhagic fever (VHF)
      • Vitamin treatment
      • Warts
      • Warts, genital
      • Weight
      • West Nile Virus (WNV)
      • Whooping cough
      • Xenotransplantation
      • Xenotropic murine leukemia virus-related virus (XMRV)
      • Yaws
    • Source files
    • Updates
    • Appendix 1: Medical criteria for the withdrawal of donations following information received after donation
    • Using these guidelines
    • Appendix 2: Immunisations
  • Cord blood
    • A to Z
      • Accident
      • Addiction and drug abuse
      • African trypanosomiasis
      • Age
      • Allergy
      • Anaemia
      • Animal bite, non-human
      • Ankylosing spondylitis (AS)
      • Anthrax
      • Antibiotic therapy
      • Arthritis
      • Asthma
      • Autoimmune disease
      • Babesiosis
      • Basal cell carcinoma (BCC)
      • Bacillus Calmette-Guérin (BCG)
      • Bleeding disorder
      • Blood pressure, high
      • Body piercing
      • Breast lump
      • Bronchitis
      • Brucellosis
      • Cardiac surgery
      • Cardiomyopathy
      • Cardiovascular disease (CVD)
      • Catarrh
      • Central nervous system (CNS) disease
      • Cervical dysplasia
      • Chickenpox
      • Chiropody
      • Chondromalacia
      • Cirrhosis
      • Clinical trials
      • Coeliac disease
      • Colostomy
      • Communication difficulties
      • Complementary therapy
      • Congo fever
      • Corneal transplant
      • Coronary thrombosis
      • Coronavirus infection
      • Deep vein thrombosis (DVT)
      • Dementia
      • Dental treatment
      • Dermatitis
      • Diabetes insipidus
      • Diabetes mellitus
      • Diarrhoea
      • Dilatation and curettage
      • Disabled mother
      • Disease of unknown aetiology
      • Diverticulosis
      • Drug treatment
      • Electrolysis
      • Emphysema
      • Endocarditis
      • Endometriosis
      • Epilepsy
      • Eye disease
      • Eye drops
      • Factor V Leiden
      • Fertility
      • Filariasis
      • Food allergy
      • Gall bladder disease
      • Giardiasis
      • Gilbert's syndrome
      • Glaucoma
      • Glucose-6-phosphate dehydrogenase (G6PD) deficiency
      • Glycogen storage disease (GSD)
      • Gout
      • Granuloma inguinale
      • Growth hormone (GH)
      • Guillain-Barré syndrome
      • Haematological disease
      • Haematuria
      • Haemochromatosis
      • Haemoglobin disorders
      • Haemolytic anaemia
      • Haemorrhoids
      • Headache
      • Heaf test
      • Healthcare worker
      • Henna painting
      • Hepatitis
      • Hepatitis A
      • Hepatitis B
      • Hepatitis C
      • Hepatitis E
      • Hepatitis of unknown origin
      • Hereditary elliptocytosis
      • Hereditary spherocytosis
      • Herpes, genital
      • Herpes, oral
      • Herpes simplex
      • Herpes zoster
      • Hormone replacement therapy (HRT)
      • Human immunodeficiency virus (HIV)
      • Human T-cell lymphotropic virus (HTLV)
      • Huntington's disease
      • Hydatid disease
      • Hydrocephalus
      • Hypnotics
      • Ileostomy
      • Immune thrombocytopenia
      • Immunisation
      • Immunisation, live
      • Immunisation, non-live
      • Immunoglobulin therapy
      • Immunosuppression
      • Infection, acute
      • Infection, chronic
      • Infection, general
      • Infection, tropical
      • Infectious diseases, contact with
      • Inflammatory bowel disease (IBD)
      • Inherited diseases
      • Inoculation injury
      • Irritable bowel syndrome (IBS)
      • Jaundice
      • Kidney disease
      • Laser treatment
      • Leishmaniasis
      • Leukaemia
      • Malaria
      • Malaria - contact in the UK
      • Malignancy
      • Mantoux test
      • Marfan syndrome
      • Measles
      • Ménière's disease
      • Meningitis
      • Mental health problems
      • Methicillin resistant staphylococcus aureus (MRSA)
      • Mitral valve prolapse
      • Mpox
      • Multiple sclerosis (MS)
      • Mumps
      • Muscular dystrophy
      • Myasthenia gravis (MG)
      • Myelodysplastic syndrome (MDS)
      • Myeloproliferative syndrome
      • Myocarditis
      • Neurofibromatosis (NF)
      • Neurosurgery
      • Night sweats
      • Non-specific urethritis (NSU)
      • Nonsteroidal anti-inflammatory drugs (NSAIDs)
      • Ocular surgery
      • Ocular tissue recipient
      • Operations
      • Organ donor
      • Organ recipient
      • Osteoarthritis
      • Osteomalacia
      • Osteomyelitis
      • Osteoporosis
      • Ovarian cyst
      • Paget's disease of bone
      • Painkillers
      • Peptic ulcer
      • Perthes disease
      • Pituitary extract, human
      • Platelet disorders
      • Pleurisy
      • Pneumothorax
      • Poisoning
      • Polycythaemia
      • Porphyria
      • Post-viral fatigue syndrome
      • Pre- and post-exposure prophylaxis (PrEP, PEP) for HIV prevention
      • Pregnancy
      • Prion-associated diseases
      • Psoriasis
      • Pulmonary embolism (PE)
      • Pyrexia
      • Pyruvate kinase deficiency (PKD)
      • Q fever
      • Rabies
      • Radiation therapy
      • Radionuclides
      • Raynaud's syndrome
      • Recipients of normal human immunoglobulin
      • Renal colic
      • Respiratory disease
      • Retinitis pigmentosa (RP)
      • Rheumatic fever
      • Rheumatoid arthritis (RA)
      • Ringworm
      • Rubella
      • Sarcoidosis
      • Self-catheterisation
      • Sex worker
      • Sexually transmitted disease (STD)
      • Shingles
      • Sickle cell trait
      • Skin disease
      • Smallpox immunisation
      • Snake bite
      • South American trypanosomiasis
      • South American trypanosomiasis, risk of
      • Spina bifida
      • Spinal surgery
      • Splenectomy
      • Steroid therapy
      • Stroke
      • Surgery
      • Syphilis
      • Systemic lupus erythematosus (SLE)
      • Tamoxifen
      • Tetanus immunisation
      • Therapeutic venesection
      • Threadworms
      • Thrombocytosis
      • Thrombosis
      • Thrush, oral
      • Thrush, vaginal
      • Thyroid disease
      • Tissue and cell allograft recipients
      • Tissues safety
      • Toxoplasmosis
      • Transfusion
      • Travel
      • Tropical viruses
      • Trypanosoma cruzi infection
      • Tuberculosis (TB)
      • Turner syndrome
      • Vasculitis
      • Viral haemorrhagic fever (VHF)
      • Vitamin treatment
      • Warts
      • Warts, genital
      • West Nile Virus (WNV)
      • Whooping cough
      • Wilson's disease
      • Xenotransplantation
      • Xenotropic murine leukemia virus-related virus (XMRV)
      • Yaws
    • Source files
    • Updates
    • Appendix 1: Medical criteria for the withdrawal of donations following information received after donation
    • Using these guidelines
    • Appendix 2: Immunisations
  • Red Book
    • Chapters
      • Introduction
        • The development of the Red Book
        • Organisation of the UK Blood and Tissue Services
        • Other relevant institutions
      • Quality in blood and tissue establishments and hospital blood banks
        • Introduction
        • Key initiatives
        • Other standards
        • Systems
        • Application of a quality management system
        • Quality management system
        • Reporting of incidents to external bodies
      • Care and selection of whole blood and component donors (including donors of pre-deposit autologous blood)
        • Introduction
        • General principles
        • Assessment of fitness to donate
        • Informed consent
        • Donor age
        • Frequency of donation
        • Volume of donation
        • Medical history of donors
        • Genetically determined conditions
        • Donors on treatment with medications (drugs)
        • Transfusion-transmissible infectious disease
        • Travel history
        • Prion-associated diseases
        • Physical examination of donors
        • Blood tests
        • Autologous donation
      • Premises and quality assurance at blood donor sessions
        • Premises
        • Staffing and training principles for donation sessions
        • Clinical leadership at donor sessions
        • Donor identification
        • Labelling
        • Records
        • Equipment and consumables
        • Protection and preservation of product quality
      • Collection of a blood or component donation
        • Information to be provided to prospective donors of blood or blood components
        • Information to be obtained from donors by Blood Establishments at every donation
        • Haemoglobin screening
        • Preparation of the venepuncture site
        • Preparation of the blood pack
        • Performance of the venepuncture
        • Whole blood donation
        • Component donation by apheresis
        • Information to be provided to the donor post-donation
        • Donor adverse events
        • Adverse events
        • Donor compensation
      • Evaluation and manufacture of blood components
        • Scope of the guidelines
        • Setting and maintaining specifications
        • Component and process monitoring tests
        • Component processing
        • Component shelf life
        • Labelling
        • Component storage
        • Non-conforming components and biohazards
        • Component release
        • Release of components which do not conform to specified requirements
        • Transportation of blood components
        • Component recall and traceability
      • Specifications for blood components
        • Introduction
        • Whole blood components
          • 7.2.1: Red Cells and Plasma, Leucocyte Depleted
        • Red cell components
          • 7.3.1: Red Cells, Leucocyte Depleted
          • 7.3.2: Red Cells in Additive Solution, Leucocyte Depleted
          • 7.3.3: Red Cells, Washed, Leucocyte Depleted
          • 7.3.4: Red Cells, Thawed and Washed, Leucocyte Depleted
        • Platelet components
          • 7.4.1: Platelets, Pooled, Buffy Coat Derived, Leucocyte Depleted
          • 7.4.2: Platelets, Apheresis, Leucocyte Depleted
          • 7.4.3: Platelets, Pooled, Buffy Coat Derived, in Additive Solution and Plasma, Leucocyte Depleted
          • 7.4.4: Platelets in Additive Solution, Leucocyte Depleted
        • Plasma components
          • 7.5.1: Fresh Frozen Plasma, Leucocyte Depleted
          • 7.5.2: Fresh Frozen Plasma, Pathogen Reduced, Leucocyte Depleted
          • 7.5.3: Cryoprecipitate, Leucocyte Depleted
          • 7.5.4: Cryoprecipitate, Pooled, Leucocyte Depleted
          • 7.5.5: Cryoprecipitate, Pooled, Pathogen Reduced, Leucocyte Depleted
          • 7.5.6: Human Plasma for Fractionation, Leucocyte Depleted
          • 7.5.7: Human Plasma for Fractionation, Cryoprecipitate Depleted, Leucocyte Depleted
        • Granulocyte components
          • 7.6.1: Granulocytes, Pooled, Buffy Coat Derived, in Platelet Additive Solution and Plasma
        • Components suitable for use in intrauterine transfusion, neonates and infants under 1 year
          • 7.7.1: Red Cells for Intrauterine Transfusion, Leucocyte Depleted
          • 7.7.2: Whole Blood for Exchange Transfusion, Leucocyte Depleted
          • 7.7.3: Red Cells for Exchange Transfusion, Leucocyte Depleted
          • 7.7.4: Red Cells for Neonates and Infants, Leucocyte Depleted
          • 7.7.5: Red Cells in Additive Solution for Neonates and Infants, Leucocyte Depleted
          • 7.7.6: Platelets for Intrauterine Transfusion, Leucocyte Depleted
          • 7.7.7: Platelets for Neonatal Use, Leucocyte Depleted
          • 7.7.8: Platelets in Plasma and Additive Solution for Neonatal Use, Leucocyte Depleted
          • 7.7.9: Fresh Frozen Plasma for Neonates and Infants, Leucocyte Depleted
          • 7.7.10: Fresh Frozen Plasma for Neonates and Infants, Pathogen Reduced, Leucocyte Depleted
          • 7.7.11: Cryoprecipitate for Neonates and Infants, Leucocyte Depleted
          • 7.7.12: Cryoprecipitate for Neonates and Infants, Pathogen Reduced, Leucocyte Depleted
      • Evaluation of novel blood components, production processes and blood packs – generic protocols
        • Aims and introduction
        • Evaluation of new red cell components for transfusion
        • Evaluation of new platelet components for transfusion
        • Evaluation of new fresh frozen plasma/cryoprecipitate components for transfusion
        • Evaluation of plasma for fractionation for the manufacture of immunoglobulin
        • Generic protocol for the evaluation of apheresis equipment
        • Generic protocol for the evaluation of blood packs for whole blood donations and apheresis collections
        • Further guidance on the evaluation of blood packs and apheresis collection systems containing new plasticisers and additive solutions, where they are combined
      • Microbiology tests for donors and donations – general specifications for laboratory test procedures
        • General requirements
        • Microbiology screening
        • Specific screening targets
        • Reinstatement of blood donors
        • Recommended standards for the reduction of bacterial contamination of blood components
        • Recommended standards for microbiological screening
        • Recommended standards for environmental monitoring of processing facilities
        • Investigation of suspected bacterial contamination of blood components
      • Investigation of suspected transfusion-transmitted infection
        • General considerations
        • Assessment of validity of the possible diagnosis of TTI
        • Non-bacterial TTI – identification of possible infectious donations
        • Investigation of possible bacterial TTI
        • Closing TTI investigations
        • Look-back investigations
      • Reagent manufacture
        • Guidelines for reagent manufacture
        • Specifications, performance evaluation and quality control of blood grouping reagents
        • Reference preparations
        • Recommended serological techniques for reagent testing
      • Donation testing (red cell immunohaematology)
        • Scope
        • General requirements
        • Samples
        • Reagents and test kits
        • Equipment
        • Test procedure
        • Reporting of results
        • Release of tested components
        • Laboratory test categories
        • Mandatory testing of blood donations
        • Additional testing
        • Donations found to have a positive direct antiglobulin test
        • Automated testing
        • Manual testing
      • Patient testing (red cell immunohaematology)
        • Scope
        • Sample acceptance and labelling
        • Pre-transfusion testing
        • Antibody quantification and titration
        • Fetomaternal haemorrhage estimation by flow cytometry
        • Post-examination
      • Guidelines for the use of DNA/PCR techniques in Blood Establishments
        • Safety precautions
        • Avoidance of contamination
        • Working practices
      • Molecular typing for red cell antigens
        • Introduction
        • Clinical applications of blood group molecular typing
        • ABO typing by molecular genetics
        • Methods available for molecular blood grouping
        • External quality assurance
      • HLA typing and HLA serology
        • Preamble
        • Introduction
        • Terminology and nomenclature
        • Reagents
        • Testing of HLA genes and gene products
        • Testing for HLA-specific antibodies
        • Leucocyte crossmatching in blood transfusion
        • Application of HLA testing to patient and donor investigations
      • Granulocyte immunology
        • Reagent manufacture, reference preparations and cell panels
        • Nomenclature
        • HNA typing methods
        • HNA antibody detection methods
        • Donor testing
        • Patient testing
      • Platelet immunology
        • Reagent manufacture and reference preparations
        • Methods
        • Donor testing
        • Patient testing
      • Tissue banking: general principles
        • Regulatory environment in the UK
        • Reference documents for tissue banking
        • Data protection and confidentiality
      • Tissue banking: selection of donors
        • General considerations
        • Consent
        • Medical and behavioural history
        • Tissue-specific donor considerations
        • Donor testing
        • Living tissue donor samples
        • Deceased tissue donor samples
        • Follow-up
        • Autologous tissue donation
        • Archiving of donor samples
        • Release criteria
      • Tissue banking: tissue retrieval and processing
        • General considerations
        • Retrieval
        • Transportation conditions from retrieval site to Tissue Establishment
        • Bacteriostasis and disinfection
        • General guidelines for tissue processing
        • Tissue storage
        • Tracking of tissues
        • Notification of serious adverse events and reactions
        • Additional guidelines for skeletal tissue retrieval and processing
        • Cardiovascular tissue retrieval and processing
        • Skin retrieval and processing
        • Ocular tissue retrieval, processing and storage
      • Haemopoietic progenitor cells
        • Introduction
        • Terminology
        • Policy and procedure requirements and safety
        • Adverse events and reactions
        • Donor selection, consent and testing
        • Collection, processing and storage
        • Testing of haemopoietic progenitor cell donors and components
        • Requirements for the timing of testing
        • Labelling, packaging, transportation and release
        • Disposal of haemopoietic progenitor cells
        • Record maintenance
      • Specification for the uniform labelling of blood, blood components and blood donor samples
        • Introduction
        • The labelling system
        • Barcode reading and interpretation
        • Donation identification number (DIN)
        • Blood group labels
        • Component labels
      • Specification for the uniform labelling of human tissue products using ISBT 128
        • Introduction
        • The labelling system
        • General requirements
        • Tissue product labels
      • Standards for electronic data interchange within the UK Blood Transfusion Services
        • Introduction
        • Control of message structures
        • General protocol
        • Envelope definition
        • Message protocols
        • Protocol 000001 - blood component dispatch information
        • Protocol 000002 - blood derivative dispatch information
        • Protocol 000003 - reagent dispatch information
        • Protocol 000004 - blood component dispatch acknowledgement
        • Protocol 000005 - blood component fate information
      • Specification for blood pack base labels
        • Introduction
        • Specification
        • Manufacturers' blood pack catalogue and lot numbers
      • Specification for labelling consumables used in therapeutic product production
        • Introduction
        • Specification
        • Manufacturers' catalogue and lot numbers
    • About the Red Book
    • Updates
    • Annex 1: NIBSC standards available from MHRA South Mimms Laboratories
    • Annex 2: ISBT 128 check character calculation
    • Annex 3: Provisional components
      • A3.1: Platelets in Additive Solution and Plasma, Leucocyte Depleted, Pathogen-reduced
      • A3.2: Red Cells in Additive Solution, Leucocyte Depleted, Pathogen Reduced
      • A3.4: Red Cells, Rejuvenated and Washed, Leucocyte Depleted
      • A3.3: Liquid Plasma, Leucocyte Depleted
      • A3.6: Whole Blood, Leucocyte Depleted, for Clinical Studies
      • A3.12: Platelets, Apheresis, in Additive Solution and Plasma, Leucocyte Depleted
      • A3.9: Cryoprecipitate, Pooled, Leucocyte Depleted, Extended Shelf-life Post-thaw
      • A3.10: Convalescent Plasma (VCOV-19), FFP, Leucocyte Depleted
      • A3.11: Dried Plasma, Leucocyte Depleted
      • A3.5: Red Cells for Neonates and Infants, Leucocyte Depleted, Washed
      • A3.13: Platelets in Additive Solution and Plasma for Neonatal Use, Leucocyte Depleted
    • Annex 4: Redundant components
      • A4.1: Granulocytes, Apheresis
      • A4.2: Convalescent Plasma (COVID-19), FFP, Leucocyte Depleted
      • A4.6: Whole Blood, Leucocyte Depleted
      • A4.3: Convalescent Plasma (COVID-19), FFP, for Neonates and Infants, Leucocyte Depleted
      • A4.4: Cryoprecipitate, Methylene Blue Treated and Removed, Leucocyte Depleted
      • A4.5: Plasma, Cryoprecipitate Depleted, Leucocyte Depleted
    • Annex 5: Contingency components
      • A5.1: Red Cells in Additive Solution, Leucocyte Depleted, Extended Shelf Life
      • A5.2: Platelets, Apheresis, Leucocyte Depleted, at Reduced Dose as a Contingency
    • Annex 6: Advanced therapy medicinal products
    • Annex 7: Requirements for the timing of testing for hematopoietic progenitor cells – minimum standards and good practice
    • PDF versions for offline use
  • Updates
    • Upcoming changes to the guidelines
• Accessibility
• Contact
• Cookies
• Privacy
• Transfusion practice
  • Consent for blood transfusion
    • Transfusion information for patients
      • Screen reader version of the 'Receiving a blood transfusion' leaflet
      • Audio version of the 'Receiving a blood transfusion' leaflet
      • Translations of the 'Receiving a blood transfusion' leaflet
    • Guidance for healthcare practitioners
      • Wrong blood/wrong patient
      • Febrile non-haemolytic reaction
      • Allergic and hypotensive reactions
      • Transfusion-Associated Circulatory Overload (TACO)
      • Non-TACO: Transfusion-Related Acute Lung Injury (TRALI)
      • Haemolytic Transfusion Reaction (HTR)
      • Transfusion-Transmitted Infection (TTI)
      • Antibody formation
      • Iron overload
      • Other complications
      • Training for consent for transfusion
      • Infected Blood Inquiry
      • Unknown risks
  • Blood transfusion e-learning
  • Clinical decision-making and authorising blood component transfusion
  • UK Cell Salvage Advisory Group
    • Equipment
    • Framework for service provision
    • Intraoperative cell salvage education
    • Competency workbooks
    • Practicalities of service provision
    • Patient resources
    • Technical factsheets and questions
    • Adverse event reporting
    • Newsletters
    • National guidance
    • Intraoperative cell salvage survey
  • Transfusion committees in the UK
  • UK and Ireland Blood Transfusion Network
• About JPAC
  • Committee members
  • Minutes of meetings
  • Terms of Reference
  • Legal framework and regulation
• Resources and documents
  • Position statements
  • Risk assessments
  • Useful resources
  • Donor haemovigilance
  • UK Red Alert Plans Group
  • Documents issued by JPAC
  • Documents issued by other bodies
  • Annual surveillance reports
• Conditions of use